Octamer

Grafelfing, Germany Founded: 2018 • Age: 8 yrs Acquired By Volition
Provider of screening substrates for epigenetics research
Request Access

About Octamer

Octamer is a company based in Grafelfing (Germany) founded in 2018 was acquired by Volition in December 2019.. Octamer operates in a competitive market with competitors including Neogen, Parse Biosciences, Qiagen, Biofidelity and Fluent BioSciences, among others.

  • Headquarter Grafelfing, Germany
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Volition

    (Dec 16, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Octamer

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Octamer

Octamer has secured backing from 1 investor. Prominent investors backing the company include Volition. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Volition is focused on developing epigenetic diagnostic solutions.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Octamer

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Octamer

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Octamer Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Octamer

Octamer operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neogen, Parse Biosciences, Qiagen, Biofidelity and Fluent BioSciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
domain founded_year HQ Location
RNA-sequencing transcriptome kits for health data analysis are developed.
domain founded_year HQ Location
Products and reagents for molecular diagnostic assays are supplied.
domain founded_year HQ Location
Molecular diagnostic assays are developed for target DNA sequence detection.
domain founded_year HQ Location
Proprietary reagents for single-cell genetic analysis are developed.
domain founded_year HQ Location
Developer of technologies for the analysis of rare and single cells in the blood
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Octamer

Frequently Asked Questions about Octamer

When was Octamer founded?

Octamer was founded in 2018.

Where is Octamer located?

Octamer is headquartered in Grafelfing, Germany. It is registered at Grafelfing, Bavaria, Germany.

What does Octamer do?

Octamer was founded in 2018 in Grafelfing, Germany, where operations center on the biotechnology sector. Screening substrates tailored for epigenetics research are offered, encompassing histones, nucleosomes, histone octamers, and DNA templates. Nucleosomes serve as control reagents in applications such as mode of action studies, biophysical profiling, and structural biology. The focus remains on supporting research needs in this specialized field.

Who are the top competitors of Octamer?

Octamer's top competitors include Neogen, Qiagen and Parse Biosciences.

Who are Octamer's investors?

Octamer has 1 investor. Key investors include Volition.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available